Release Date: 12/03/10 15:43 Summary: Top 20 securityholders after share consolidation Price Sensitive: No Download Document 386.23KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling